NDC 70710-1221-01 - CARBIDOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1221
- Requested NDC
- 70710-1221-01
- Package NDCs from labels
- 70710-1221-1, 70710-1221-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2023-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CARBIDOPA - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2023-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1221-1 | CARBIDOPA | 100 in 1 BOTTLE | TABLET | 100 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1221 | CARBIDOPA TABLET [ZYDUS PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230917_c0b1ef99-3092-431a-8fb6-897affd52595.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1221-1 | EA - Each | 70710-1221 | 743b5c3e-a5fd-42ee-b4c0-073005ef0c86 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Carbidopa | CARBIDOPA | NorthStar Rx LLC | 33ee4598-cbcc-45e0-a48e-dc0101e1f204 | 2022-11-03 | Warnings, Adverse reactions | 260260 MNX7R8C5VO |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | Aphena Pharma Solutions - Tennessee, LLC | 64254508-dbe7-4512-902d-f4a6ef2bfdf8 | 2022-10-18 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Aphena Pharma Solutions - Tennessee, LLC | 289ca0b7-1b4f-4653-b329-066447d18c13 | 2022-05-11 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Proficient Rx LP | 0215da3f-13a0-400d-ac2d-20c839bd89ef | 2022-04-01 | Warnings, Adverse reactions | MNX7R8C5VO |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Sun Pharmaceutical Industries, Inc. | 829c35f9-ace0-11dd-8800-f3e252b43544 | 2021-08-13 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa | CARBIDOPA | Aurobindo Pharma Limited | ed98c7e1-78a6-43a5-92cd-4f085af6f09d | 2021-04-29 | Warnings, Adverse reactions | 260260 MNX7R8C5VO |
| Carbidopa | CARBIDOPA TABLETS | Oceanside Pharmaceuticals | d5204e5e-10ef-4758-8fc6-cb710048c687 | 2020-07-02 | Warnings, Adverse reactions | 260260 MNX7R8C5VO |
| Lodosyn | CARBIDOPA | Bausch Health US, LLC | ff8e105b-7415-42d4-bbb2-b36cfb8945a5 | 2020-07-01 | Warnings, Adverse reactions | 260260 MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Limited | a85a56c5-44dd-41d4-ac1c-bdc4758406a4 | 2019-06-06 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa | CARBIDOPA | Novel Laboratories, Inc. | 7e5c9666-7a7c-4b64-87e4-7be6ae53603e | 2017-06-01 | Warnings, Adverse reactions | 260260 MNX7R8C5VO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.